Lastly, we correlated a composite adenosine signature with tumorous IL-6 expression in NSCLC to better understand the potential role of the IL-6-adenosine axis in mediating poor outcomes to ICIs. The gene discussed is IL6; the disease is non-small cell lung carcinoma.